Furthermore, mangiferin downregulates the contents of IL-18, IL-1β, IL-6, and TNF-α in the hippocampus of the CUMS-induced depression mouse model by inhibiting the NLRP3/ASC/caspase-1 pathway (Cao et al., 2017). Here, CASP1 is linked to depressive symptom measurement.